Basel Medical Group LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G: Rainforest Capital VCC and Affiliates Disclose Majority Stake in Basel Medical Group Ltd Post-IPO
Rainforest Capital VCC, along with Mengli Chen and Keng Leong Fung, has disclosed a beneficial ownership of 54.2% in Basel Medical Group Ltd, totaling 10,174,579 ordinary shares, following the company's initial public offering.